Advertisement

Cancer

  • David V. Schapira
  • J. Donald Temple

Abstract

In 1975 the likelihood that an American would develop cancer in his/her lifetime was 30%. By 1985 this had risen to 35% and by the year 2000 the risk will be 40%. During the period 1968–1978 the age-adjusted death rate due to cancer rose by 5%.1 The rates of the other most common causes of death all fell—coronary artery disease by 22%, cerebral vascular disease by 36%, and accidents by 22%. Despite this rather alarming rise in cancer incidence, the National Cancer Institute has set a goal to reduce the mortality from cancer by 50% by the year 2000. This goal, though, is not unreasonable. It relies on the implementation of strategies for preventing cancer. Primary-care physicians will play a vital role in this effort by educating their patients and the general public.

Keywords

Breast Cancer Cervical Cancer Bile Acid Endometrial Cancer Small Cell Carcinoma 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Ries, L. G., Pollock, E. S., Young, J. L., Jr.: Cancer patient survival: Surveillance, Epidemiology and End Results: Incidence and Mortality Data, 1973-1977. JNCI 70: 693–707, 1983.PubMedGoogle Scholar
  2. 2.
    Doll, R., and Peto, R.: The causes of cancer. J. Natl. Cancer Inst. 66: 1197–1312, 1981.Google Scholar
  3. 3.
    Boutwell, R. K.: Biochemical mechanism of tumor promotion. Carcinogenesis 2: 49–59, 1978.Google Scholar
  4. 4.
    Dull, R. (ed.): Cancer Incidence in Five Continents. Vol. IV. Springer-Verlag, 1982.Google Scholar
  5. 5.
    Buell, P.: Changing incidence in breast cancer in Japanese-American women. J. Natl. Cancer Inst. 51: 1473–1479, 1973.Google Scholar
  6. 6.
    Haenszel, W., and Kurihara, M.: Studies of Japanese migrants: Mortality from cancer and other diseases among Japanese in the United States. J. Natl. Cancer Inst. 40: 43–68, 1968.PubMedGoogle Scholar
  7. 7.
    Carroll, K. K., and Khor, H. T.: Dietary fat in relation to tumorigenesis. Prog. Biochem. Pharmacol. 10: 308–353, 1975.PubMedGoogle Scholar
  8. 8.
    Nicholson, W. J.: Cancer following occupational exposure to asbestos and vinyl chloride. Cancer 39: 1792, 1977.PubMedCrossRefGoogle Scholar
  9. 9.
    Brewster, L., and Jacobson, M. F.: The Changing American Diet. Center for Science in the Public Interest, Washington, DC, 1978.Google Scholar
  10. 10.
    Hirayama, T.: Epidemiology of breast cancer with special reference to the role of diet. Prev. Med. 7: 178–195, 1978.Google Scholar
  11. 11.
    De Waard, E.: Breast cancer incidence and nutritional status with particular reference to body weight and height. Cancer Res. 35: 3351–3356, 1975.PubMedGoogle Scholar
  12. 12.
    Carroll, K. K., and Khor, H. T.: Effects of level and type of dietary fat on incidence of mammarv tumors induced in female Sprague-Dawley rats by 7,12 dimethyl-benz (a) anthracence. Lipids 6: 415–420, 1971.PubMedCrossRefGoogle Scholar
  13. 13.
    Carroll, K. K., and Hopkins, G. J.: Dietary polyunsaturated fat versus saturated fat in relation to mammary carcinogenesis. Lipids 14: 155–158, 1978.CrossRefGoogle Scholar
  14. 14.
    Shin, R. P. C., Lima, G., and Iwasiow, B.: Prolactin inducible proteins in human breast cancer cells. 7th Int. Cong. of Endocrine, 1984, p. 983.Google Scholar
  15. 15.
    Hill, P., and Wynder, E. L.: Diet and prolactin release. Lancet 2: 806–807, 1976.PubMedCrossRefGoogle Scholar
  16. 16.
    Hill, D. L., and Grubbs, C. J.: Retinoids as chemopreventive and anticancer agents in intact animals. Anticancer Res. 2: 111–124, 1982.PubMedGoogle Scholar
  17. 17.
    Sporn, M. B., and Newton, D. L.: Chemoprevention of cancer with retinoids. Fed. Proc. Fed. Am. Soc. Exp. Bio. 38: 2528–2534, 1979.Google Scholar
  18. 18.
    Russell, M. A. H., Wilson, C., and Taylor, C., et al.: Effect of general practitioners’ advice against smoking. Br. Med. J. 2: 231–235, 1979.PubMedCrossRefGoogle Scholar
  19. 19.
    Schapira, D. V., and Pozo, C.: Physicians, nurses, and medical students knowledge of cancer prevention and nutrition. Journal of Cancer Education 1: 201, 1986.Google Scholar
  20. 20.
    Cancer statistics, 1985. Ca 36: 16–24, 1986.Google Scholar
  21. 21.
    Richart, R. M., and Barron, B. A.: Screening strategies for cervical cancer and cervical intraepithelial neoplasia. Cancer 47: 1176–1181, 1981.PubMedCrossRefGoogle Scholar
  22. 22.
    Stern, E., and Neely, P. M.: Dysplasia of the uterine cervix: Incidence of regression, recurrence and cancer. Cancer 17: 508, 1964.PubMedCrossRefGoogle Scholar
  23. 23.
    Barron, B. A., and Richart, R. M.: Statistical model of the natural history of cervical carcinoma. J. Natl. Cancer Inst. 45: 1025–1030, 1979.Google Scholar
  24. 24.
    American Cancer Society recommendations for the early detection of cancer in asymptomatic people. Ca 35: 199, 1985.Google Scholar
  25. 25.
    Carlile, T.: Breast cancer detection. Cancer 47: 1164–1169, 1981.PubMedCrossRefGoogle Scholar
  26. 26.
    Nasca, P. C., Baptiste, M. S., and Greenwald, P.: Issues in Cancer Screening. Cancer Prevention in Clinical Medicine. Raven Press, New York, 1983.Google Scholar
  27. 27.
    Miller, A. B.: Breast cancer. Cancer 47: 1109–1113, 1981.PubMedCrossRefGoogle Scholar
  28. 28.
    Foster, R. S., and Costanza, M. C.: Breast self-examination practices and breast cancer survival. Cancer 53: 999–1005, 1984.PubMedCrossRefGoogle Scholar
  29. 29.
    Greenwald, P., Lawrence, C., Horton, J., et al.: Effect of breast self examination and routine physical examinations on breast cancer mortality. N. Engl. J. Med. 199: 271–273, 1978.CrossRefGoogle Scholar
  30. 30.
    Feldman, J., Carter, A., Nicastri, A., et al.: Breast self examination: Relationship to stage of breast cancer at diagnosis. Cancer 47: 2740–2745, 1981.PubMedCrossRefGoogle Scholar
  31. 31.
    Shapiro, S., Strax, P., and Venet, L.: Periodic breast cancer screening, the first two years of screening. Arch. Environ. Health 15: 547–553, 1967.PubMedGoogle Scholar
  32. 32.
    Shapiro, S.: Evidence on screening for breast cancer from a randomized trial. Cancer 39: 2772–2782, 1977.PubMedCrossRefGoogle Scholar
  33. 33.
    Wertheimer, M. D., Costanza, M. E., Dodson, T. F., et al.: Increasing the effort toward breast cancer detection. JAMA 255: 1311–1315, 1986.PubMedCrossRefGoogle Scholar
  34. 34.
    DeVita, V. T., Hellman, S., and Rosenberg, S. A. (eds.): Cancer—Principles and Practice of Oncology. Lippincott, Philadelphia, 1985, pp. 1130–1131.Google Scholar
  35. 35.
    Melamed, M. R., Flehinger, B. U., Zaman, M. B., et al.: Detection of true pathologic stage I lung cancer in a screening program and the effect on survival. Cancer 47: 1182–1187, 1981.PubMedCrossRefGoogle Scholar
  36. 36.
    Taylor, W. F., Fontana, R. S., Uhlenhopp, M. A. et al.: Some results of screening for early lung cancer. Cancer 47: 1114–1120, 1981.PubMedCrossRefGoogle Scholar
  37. 37.
    Simon, J. B.: Occult blood screening for colorectal carcinoma: A critical review. Gastroenterology 88: 820–837, 1985.PubMedGoogle Scholar
  38. 38.
    Gilbertsen, V. A., and Nelms, J. M.: The prevention of invasive cancer of the rectum. Cancer 41: 1137–1139, 1978.PubMedCrossRefGoogle Scholar
  39. 39.
    Gilbertsen, V. A.: Proctosigmoidoscopy and polypectomy in reducing the incidence of rectal cancer. Cancer 34: 936–939, 1974.PubMedCrossRefGoogle Scholar
  40. 40.
    Bolt, R. J.: Sigmoidoscopy in detection and diagnosis in the asymptomatic individual. Cancer 28: 230–232, 1971.CrossRefGoogle Scholar
  41. 41.
    Winawer, S. J.: Detection and diagnosis of colorectal cancer. Cancer 51: 2519–2524, 1983.PubMedCrossRefGoogle Scholar
  42. 42.
    Berlin, N. I.: Tumor markers in cancer prevention and detection. Cancer 47: 1151–1153, 1981.PubMedCrossRefGoogle Scholar
  43. 43.
    Tests for occult blood. Med. Lett. 28(705): 5–6, 1986.Google Scholar
  44. 44.
    Greene, M. H., Clark, W. H., Tucker, M. A., et al.: Acquired precursors of cutaneous malignant melanoma. N. Engl. J. Med. 312: 91–97, 1985.PubMedCrossRefGoogle Scholar
  45. 45.
    Fitzpatrick, T. B., Rhodes, A. R., and Sober, A. J.: Prevention of melanoma by recognition of its precursors. N. Engl. J. Med. 312: 115–116, 1985.PubMedCrossRefGoogle Scholar
  46. 46.
    Arndt, K. A.: Precursors to malignant melanoma: Congenital and dysplastic nevi. JAMA 251: 1882–1883, 1984.PubMedCrossRefGoogle Scholar
  47. 47.
    Friedman, R. J.: Early detection of malignant melanoma: The role of the physician examination and self examination of the ski. Ca 35: 130–151, 1985.PubMedGoogle Scholar
  48. 48.
    Consensus conference on precursors to malignant melanoma. J. Dermatol. Surg. Oncol. 11: 537–542, 1985.Google Scholar
  49. 49.
    Gusberg, S. B., and Milano, C.: Detection of endometrial cancer and its precursors. Cancer 47: 1173–1175, 1981.PubMedCrossRefGoogle Scholar
  50. 50.
    Eddy, D. M.: The economics of cancer prevention and detection: Getting more for less. Cancer 47: 1200–1209, 1981.PubMedCrossRefGoogle Scholar

Copyright information

© Plenum Publishing Corporation 1988

Authors and Affiliations

  • David V. Schapira
    • 1
  • J. Donald Temple
    • 2
  1. 1.H. Lee Moffitt Cancer CenterUniversity of South Florida College of MedicineTampaUSA
  2. 2.Department of MedicineUniversity of Miami School of MedicineMiamiUSA

Personalised recommendations